Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffry J Cutrera

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|March 13, 2012
Coordination between TLR9 signaling in macrophages and CD3 signaling in T cells induces robust expression of IL-30Denada Dibra, Jeffry J Cutrera, Shulin Li
Cancer Research|June 25, 2009
Expression of WSX1 in tumors sensitizes IL-27 signaling-independent natural killer cell surveillanceDenada Dibra, Jeffry J Cutrera, Xueqing Xia, et al.
Hepatology (Baltimore, Md.)|December 7, 2015
Mutant p53 in concert with an interleukin-27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in miceDenada Dibra, Xueqing Xia, Abhisek Mitra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2016
Lack of Immunomodulatory Interleukin-27 Enhances Oncogenic Properties of Mutant p53 In VivoDenada Dibra, Abhisek Mitra, Melisa Newman, et al.
Oncotarget|October 15, 2016
IL27 controls skin tumorigenesis via accumulation of ETAR-positive CD11b cells in the pre-malignant skinDenada Dibra, Abhisek Mitra, Melissa Newman, et al.
Cancer Research|January 23, 2014
Universal marker and detection tool for human sarcoma circulating tumor cellsArun Satelli, Abhisek Mitra, Jeffry J Cutrera, et al.
Gynecologic Oncology|September 15, 2018
A practical guide for the safe implementation of early phase drug development and immunotherapy program in gynecologic oncology practiceAmir Jazaeri, Robert L Coleman, Anil K Sood, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Immunology (Baltimore, Md. : 1950)|March 13, 2012
Coordination between TLR9 signaling in macrophages and CD3 signaling in T cells induces robust expression of IL-30Denada Dibra, Jeffry J Cutrera, Shulin Li
Cancer Research|June 25, 2009
Expression of WSX1 in tumors sensitizes IL-27 signaling-independent natural killer cell surveillanceDenada Dibra, Jeffry J Cutrera, Xueqing Xia, et al.
Hepatology (Baltimore, Md.)|December 7, 2015
Mutant p53 in concert with an interleukin-27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in miceDenada Dibra, Xueqing Xia, Abhisek Mitra, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2016
Lack of Immunomodulatory Interleukin-27 Enhances Oncogenic Properties of Mutant p53 In VivoDenada Dibra, Abhisek Mitra, Melisa Newman, et al.
Oncotarget|October 15, 2016
IL27 controls skin tumorigenesis via accumulation of ETAR-positive CD11b cells in the pre-malignant skinDenada Dibra, Abhisek Mitra, Melissa Newman, et al.
Cancer Research|January 23, 2014
Universal marker and detection tool for human sarcoma circulating tumor cellsArun Satelli, Abhisek Mitra, Jeffry J Cutrera, et al.
Gynecologic Oncology|September 15, 2018
A practical guide for the safe implementation of early phase drug development and immunotherapy program in gynecologic oncology practiceAmir Jazaeri, Robert L Coleman, Anil K Sood, et al.
Pageof 1